tiprankstipranks
Trending News
More News >
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market

Bicara Therapeutics Inc. (BCAX) Cash flow

Compare
71 Followers

Bicara Therapeutics Inc. Cash Flow

BCAX's free cash flow for Q3 2025 was $-29.29M. For the 2025 fiscal year, BCAX's free cash flow was decreased by $-28.61M and operating cash flow was $-29.25M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22
Operating Cash Flow
$ -74.75M$ -45.63M$ -32.08M
Investing Cash Flow
$ -9.00K$ -586.00K$ -192.00K
Financing Cash Flow
$ 334.03M$ 272.50M$ 31.70M
End Cash Position
$ 489.71M$ 230.44M$ 4.16M
Free Cash Flow
$ -74.82M$ -46.21M$ -32.27M
Currency in USD

Bicara Therapeutics Inc. Cash Flow